Journal of Hepatology
Volume 47, Issue 2 , Pages 191-202 , August 2007

Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B

  • Chee-Kin Hui

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • Research Centre of Infection and Immunity, The University of Hong Kong, Hong Kong SAR, China
    • Corresponding Author InformationCorresponding author. Tel.: +852 28184300; fax: +852 28184030.
    • ,
  • Hai-Ying Zhang

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Nikki P. Lee

      Affiliations

    • Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Weng Chan

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Yui-Hung Yueng

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Kar-Wai Leung

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Lei Lu

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Nancy Leung

      Affiliations

    • Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong SAR, China
    • ,
  • Chung-Mau Lo

      Affiliations

    • Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Sheung-Tat Fan

      Affiliations

    • Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • John M. Luk

      Affiliations

    • Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Aimin Xu

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Karen S. Lam

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • Yok-Lam Kwong

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • George K.K. Lau

      Affiliations

    • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
    • Research Centre of Infection and Immunity, The University of Hong Kong, Hong Kong SAR, China
    • ,
  • for The Hong Kong Liver Fibrosis Study Group

Received 14 December 2006 ,Revised 16 January 2007 ,Accepted 28 February 2007.

References 

  1. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24:29–33
  2. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003;52:239–243
  3. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112:91–100
  4. Tacke F, Wustefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol. 2005;42:666–673
  5. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology. 2003;125:1796–1807
  6. Tietge UJ, Boker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab. 2004;287:E82–E89
  7. Jonsson JR, Moschen AR, Hickman IJ, Ricardson MM, Kaser S, Clouston AD, et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol. 2005;43:929–936
  8. Liu CJ, Chen PJ, Jeng YM, Huang WL, Yang WS, Lai MY, et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol. 2005;43:235–242
  9. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat T, Cooksley G, et al. Peginterferon alfa-2a (40kDa) (PEGASYS) monotherapy and in combination with lamivudine is more effective than lamivudine monotherapy in HBeAg positive chronic hepatitis B: results from a large, multinational study. N Eng J Med. 2005;352:2682–2695
  10. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–430
  11. Hui CK, Lie A, Au WY, Leung YH, Ma SY, Cheung WW, et al. A long-term follow-up study on hepatitis B surface antigen positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood. 2005;106:464–469
  12. Hui CK, Lau E, Monto A, Kim M, Luk JM, Poon RT, et al. Natural history of patients with recurrent chronic hepatitis C virus and occult hepatitis B co-infection after liver transplantation. Am J Transplant. 2006;6:1600–1608
  13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med. 2004;15:539–553
  14. Ishak KG, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699
  15. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280:18073–18080
  16. Corbetta S, Bulfamante G, Cortelazzi D, Barresi I, Mantovani G, Bondioni S, et al. Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab. 2005;90:2397–2402
  17. Hui CK, Cheung WW, Zhang HY, Au WY, Yueng YH, Leung AY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg negative patients undergoing cytotoxic chemotherapy. Gastroenterology. 2006;131:59–68
  18. Lau GK, Leung YH, Fong DY, Au WY, Kwong YL, Lie A, et al. High hepatitis B virus (HBV) DNA as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood. 2002;99:2324–2330
  19. Hui CK, Lai L, Lam P, Zhang HY, Fung TT, Wong WM, et al. 48 weeks pegylated interferon alfa-2a is superior to 24 weeks of pegylated interferon alfa-2b in achieving HBeAg seroconversion in chronic hepatitis B infection. Aliment Pharmacol Ther. 2006;23:1171–1178
  20. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439–451
  21. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148:293–300
  22. Kaser S, Moschen A, Kaser A, Ludwiczek O, Ebenbichler CF, Vogel W, et al. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med. 2005;258:274–280
  23. Sohara N, Takagi H, Kakizaki S, Sato K, Mori M. Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels. Liver Int. 2005;25:28–32
  24. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res. 2004;94:e27–e31
  25. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279:12152–12162
  26. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem. 2005;280:18341–18347
  27. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30kDa (Acrp30). J Biol Chem. 2002;277:29359–29362
  28. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Eng J Med. 1999;341:1256–1263
  29. Lau GK, Cooksley G, Marcellin P, Piratvisuth T, Hadziyannis S, Dunant H, et al. Predictors of histologic improvement and relationship between sustained response and histology in patients with HBeAg positive and HBeAg netaive chronic hepatitis B treated with Peginterferon alpha 2a (40kDa)(PEGASYS). Hepatology. 2005;42:587A
  30. Liaw YF, Sung JJ, Chow WC, Farrell GC, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521–1531
  31. Wu PC, Lok AS, Lau JY, Lauder IJ, Lai CL. Histologic changes in Chinese patients with chronic hepatitis B virus infection after interferon-α therapy. Am J Clin Pathol. 1992;98:402–407
  32. Hadziyannis S, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Eng J Med. 2005;352:2673–2681

☆ The authors who have taken part in this study declared that they did not receive funding from the manufacturers to carry out their research. They received funding from the Hong Kong Liver Foundation which enabled them to carry out their study.

PII: S0168-8278(07)00146-8

doi: 10.1016/j.jhep.2007.02.023

Journal of Hepatology
Volume 47, Issue 2 , Pages 191-202 , August 2007

Article Tools

* Image Usage & Resolution